Pharsight

Rayner Surgical patents expiration

1. Omidria patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8586633 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(a month ago)

US9278101 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(a month ago)

US8173707 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(a month ago)

US9399040 RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jul, 2023

(a month ago)

US9399040

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(4 months from now)

US8173707

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(4 months from now)

US8586633

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(4 months from now)

US9278101

(Pediatric)

RAYNER SURGICAL Ophthalmologic irrigation solutions and method
Jan, 2024

(4 months from now)

US9486406 RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Oct, 2033

(10 years from now)

US9066856 RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Oct, 2033

(10 years from now)

US9855246 RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Oct, 2033

(10 years from now)

US9486406

(Pediatric)

RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Apr, 2034

(10 years from now)

US9066856

(Pediatric)

RAYNER SURGICAL Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Apr, 2034

(10 years from now)

Drugs and Companies using KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 May, 2014

Treatment: Maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain

Dosage: SOLUTION;IRRIGATION

How can I launch a generic of OMIDRIA before it's drug patent expiration?
More Information on Dosage

OMIDRIA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic